These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1789061)

  • 1. Prolactin responses to vasoactive intestinal polypeptide and thyrotropin releasing hormone in chronic renal failure.
    Arnaout MA; Hamzeh YS; Ajlouni KM
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):651-6. PubMed ID: 1789061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vasoactive intestinal polypeptide, TRH, and dopamine on prolactin secretion in estrogen-primed postmenopausal women.
    Couzinet B; Dorey F; Schaison G
    Acta Endocrinol (Copenh); 1989 Aug; 121(2):235-40. PubMed ID: 2505467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of prolactin during four-day osmotic pump infusion of thyrotropin-releasing hormone and vasoactive intestinal polypeptide in rats.
    Niimi M; Takahara J; Kawanishi K
    Endocrinol Jpn; 1985 Dec; 32(6):929-32. PubMed ID: 3938733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer.
    Ohgo S; Kato Y; Chihara K; Imura H
    Cancer; 1976 Mar; 37(3):1412-6. PubMed ID: 816451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological roles of thyrotrophin-releasing hormone and vasoactive intestinal peptide on the pulsatile secretory patterns of prolactin in pituitary-grafted female rats.
    Lafuente A; Marcó J; Esquifino AI
    J Endocrinol; 1994 Sep; 142(3):581-6. PubMed ID: 7964307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thyroid status on the prolactin-releasing action of vasoactive intestinal peptide in humans: comparison with the action of thyrotropin-releasing hormone.
    Watanobe H; Sasaki S
    Neuroendocrinology; 1995 Feb; 61(2):207-12. PubMed ID: 7753340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
    Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
    J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly.
    Chihara K; Kaji H; Minamitani N; Kodama H; Kita T; Goto B; Chiba T; Coy DH; Fujita T
    J Clin Endocrinol Metab; 1984 Jan; 58(1):81-6. PubMed ID: 6417157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.
    Iglesias P; Selgas R; Méndez J; Fernández-Reyes MJ; Bajo MA; Aguilera A; Díez JJ
    Nephrol Dial Transplant; 2000 Jun; 15(6):856-61. PubMed ID: 10831641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of prolactin response to thyrotropin-releasing hormone and metoclopramide in chronic renal failure.
    Leroith D; Danovitz G; Trestan S; Spitz IM
    J Clin Endocrinol Metab; 1979 Dec; 49(6):815-7. PubMed ID: 117018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
    Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
    Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of oestrogens for the sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man.
    Pizzi M; Rubessa S; Simonazzi E; Zanagnolo V; Falsetti L; Memo M; Spano PF
    J Endocrinol; 1992 Feb; 132(2):311-6. PubMed ID: 1541929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.